These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34785000)

  • 1. Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals.
    Braune K; Lal RA; Petruželková L; Scheiner G; Winterdijk P; Schmidt S; Raimond L; Hood KK; Riddell MC; Skinner TC; Raile K; Hussain S;
    Lancet Diabetes Endocrinol; 2022 Jan; 10(1):58-74. PubMed ID: 34785000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey.
    Braune K; Gajewska KA; Thieffry A; Lewis DM; Froment T; O'Donnell S; Speight J; Hendrieckx C; Schipp J; Skinner T; Langstrup H; Tappe A; Raile K; Cleal B
    J Med Internet Res; 2021 Jun; 23(6):e25409. PubMed ID: 34096874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers.
    Morrison AE; Senior PA; Bubela T; Farnsworth K; Witteman HO; Lam A
    Can J Diabetes; 2022 Dec; 46(8):863-870. PubMed ID: 35945126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Learning challenges of healthcare professionals supporting open-source automated insulin delivery.
    Crocket H; Lewis DM; Burnside M; Faherty A; Wheeler B; Frewen C; Lever C; Jefferies C; Williman J; Sanders O; Wilson R; Paul R; Price S; Jones S; de Bock M
    Diabet Med; 2022 May; 39(5):e14750. PubMed ID: 34826158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals.
    Jennings P; Hussain S
    J Diabetes Sci Technol; 2020 Sep; 14(5):868-877. PubMed ID: 31847570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals.
    Ahmed SH; Ewins DL; Bridges J; Timmis A; Payne N; Mooney C; MacGregor C
    Adv Ther; 2020 Sep; 37(9):3929-3941. PubMed ID: 32696329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.
    Sherr JL; Heinemann L; Fleming GA; Bergenstal RM; Bruttomesso D; Hanaire H; Holl RW; Petrie JR; Peters AL; Evans M
    Diabetes Care; 2022 Dec; 45(12):3058-3074. PubMed ID: 36202061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do-It-Yourself Automated Insulin Delivery: A Leading Example of the Democratization of Medicine.
    Burnside M; Crocket H; Mayo M; Pickering J; Tappe A; de Bock M
    J Diabetes Sci Technol; 2020 Sep; 14(5):878-882. PubMed ID: 31876179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice.
    Phillip M; Nimri R; Bergenstal RM; Barnard-Kelly K; Danne T; Hovorka R; Kovatchev BP; Messer LH; Parkin CG; Ambler-Osborn L; Amiel SA; Bally L; Beck RW; Biester S; Biester T; Blanchette JE; Bosi E; Boughton CK; Breton MD; Brown SA; Buckingham BA; Cai A; Carlson AL; Castle JR; Choudhary P; Close KL; Cobelli C; Criego AB; Davis E; de Beaufort C; de Bock MI; DeSalvo DJ; DeVries JH; Dovc K; Doyle FJ; Ekhlaspour L; Shvalb NF; Forlenza GP; Gallen G; Garg SK; Gershenoff DC; Gonder-Frederick LA; Haidar A; Hartnell S; Heinemann L; Heller S; Hirsch IB; Hood KK; Isaacs D; Klonoff DC; Kordonouri O; Kowalski A; Laffel L; Lawton J; Lal RA; Leelarathna L; Maahs DM; Murphy HR; Nørgaard K; O'Neal D; Oser S; Oser T; Renard E; Riddell MC; Rodbard D; Russell SJ; Schatz DA; Shah VN; Sherr JL; Simonson GD; Wadwa RP; Ward C; Weinzimer SA; Wilmot EG; Battelino T
    Endocr Rev; 2023 Mar; 44(2):254-280. PubMed ID: 36066457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world evidence on clinical outcomes of people with type 1 diabetes using open-source and commercial automated insulin dosing systems: A systematic review.
    Knoll C; Peacock S; Wäldchen M; Cooper D; Aulakh SK; Raile K; Hussain S; Braune K
    Diabet Med; 2022 May; 39(5):e14741. PubMed ID: 34773301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do-it-yourself closed-loop systems for people living with type 1 diabetes.
    Dowling L; Wilmot EG; Choudhary P
    Diabet Med; 2020 Dec; 37(12):1977-1980. PubMed ID: 32420640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. User and Healthcare Professional Perspectives on Do-It-Yourself Artificial Pancreas Systems: A Need for Guidelines.
    Shepard JA; Breton M; Nimri R; Roberts JTF; Street T; Klonoff D; Barnard-Kelly K
    J Diabetes Sci Technol; 2022 Jan; 16(1):224-227. PubMed ID: 33000636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.
    Lewis DM; Hussain S
    Diabetes Ther; 2022 Sep; 13(9):1683-1699. PubMed ID: 35913655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G.
    Jeyaventhan R; Gallen G; Choudhary P; Hussain S
    Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes: consensus statement of the ADS/ADEA/APEG/ADIPS Working Group.
    Pease AJ; Andrikopoulos S; Abraham MB; Craig ME; Fenton B; Overland J; Price S; Simmons D; Ross GP
    Med J Aust; 2021 Nov; 215(10):473-478. PubMed ID: 34148253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human-in-the-Loop Insulin Dosing.
    Bequette BW
    J Diabetes Sci Technol; 2021 May; 15(3):699-704. PubMed ID: 31801361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Type 1 Diabetes Mellitus Using Open-Source Automated Insulin Delivery During Pregnancy: A Case Series.
    Schütz AK; Schütz-Fuhrmann I; Stadler M; Staudinger H; Mader JK
    Diabetes Technol Ther; 2022 Mar; 24(3):227-230. PubMed ID: 34542371
    [No Abstract]   [Full Text] [Related]  

  • 20. Automated Insulin Delivery Systems: Hopes and Expectations of Family Members.
    Garza KP; Jedraszko A; Weil LEG; Naranjo D; Barnard KD; Laffel LMB; Hood KK; Weissberg-Benchell J
    Diabetes Technol Ther; 2018 Mar; 20(3):222-228. PubMed ID: 29565721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.